Wird geladen...

Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type

Clinical tools to guide in the appropriate treatment selection in immunoglobulin light chain (AL) amyloidosis are not well developed. We evaluated the response and outcome for various regimens at first-line treatment (n=681) and first progression (n=240) stratified by the immunoparesis status at dia...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Haematologica
Hauptverfasser: Muchtar, Eli, Dispenzieri, Angela, Kumar, Shaji K., Dingli, David, Lacy, Martha Q., Buadi, Francis K., Hayman, Suzanne R., Kapoor, Prashant, Leung, Nelson, Chakraborty, Rajshekhar, Russell, Stephen, Lust, John A., Lin, Yi, Go, Ronald S., Zeldenrust, Steven, Kyle, Robert A., Rajkumar, S. Vincent, Gertz, Morie A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Ferrata Storti Foundation 2016
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5060027/
https://ncbi.nlm.nih.gov/pubmed/27479823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2016.147041
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!